Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives
| dc.contributor.author | Demirayak, Şeref | |
| dc.contributor.author | Yurttas, Leyla | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T19:58:05Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T19:58:05Z | |
| dc.date.issued | 2014 | |
| dc.department | İstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Ana Bilim Dalı | |
| dc.description | WOS: 000345518000007 | |
| dc.description | PubMed ID: 24456294 | |
| dc.description.abstract | The synthesis of some new pyrazino[1,2-a]benzimidazole derivatives and investigation of their anticancer activities were aimed in this work. Thus, 2-acetylbenzimidazole was reacted with appropriate alpha-bromoacetophenones and potassium carbonate in acetone to give 2-(2-acetyl-1H-benzimidazol-1-yl)-1-phenylethanone derivatives (3a-d). These diketone compounds were reacted with varied benzylamines in acetic acid to obtain 2-benzyl-1-methylidene-3-aryl-1,2-dihydropyrazino[1,2-a]benzimidazole derivatives (4a-t). The structures of the obtained compounds were elucidated by using IR, H-1-NMR, C-13-NMR, MS spectral data and elemental analyses results. Anticancer activities of the selected compounds were investigated in National Cancer Institute, Bethesda, MD. 3c and 4n showed remarkable anticancer activity comparing with standard drugs, melphalan and cisplatin. | |
| dc.identifier.citation | Demirayak, Ş. ve Yurttas, L. (2014). Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(6), 811-822. https://dx.doi.org/10.3109/14756366.2013.858142 | |
| dc.identifier.doi | 10.3109/14756366.2013.858142 | |
| dc.identifier.endpage | 822 | |
| dc.identifier.issn | 1475-6366 | |
| dc.identifier.issn | 1475-6374 | |
| dc.identifier.issue | 6 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 811 | |
| dc.identifier.uri | https://dx.doi.org/10.3109/14756366.2013.858142 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/3104 | |
| dc.identifier.volume | 29 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis | |
| dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | 1,2-Disubstituted Benzimidazole | |
| dc.subject | Alpha,Beta-Unsaturated Carbonyl | |
| dc.subject | Anticancer Activity | |
| dc.subject | Pyrazino[1,2-a]Benzimidazole | |
| dc.title | Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Demirayak, Seref-2014.pdf
- Boyut:
- 1.69 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text











